Adherence to treatment in allergic respiratory diseases

被引:17
|
作者
Baiardini, Ilaria [1 ]
Novakova, Silviya [2 ]
Mihaicuta, Stefan [3 ]
Oguzulgen, Ipek Kivilcim [4 ]
Canonica, Giorgio Walter [1 ,5 ]
机构
[1] Humanitas Univ, Dept Biomed Sci, Milan, Italy
[2] Univ Hosp St George, Internal Consulting Dept, Allergy Unit, Plovdiv, Bulgaria
[3] Univ Med & Pharm Dr Victor Babes, CardioPrevent Fdn, Pulmonol Dept, Timisoara, Romania
[4] Gazi Univ, Dept Pulm Dis, Sch Med, Ankara, Turkey
[5] Humanitas Res Hosp, Personalized Med Asthma & Allergy Clin, Milan, Italy
关键词
Adherence; allergic rhinitis; asthma; education; new technologies; QUALITY-OF-LIFE; INHALED CORTICOSTEROID ADHERENCE; AUDIOVISUAL REMINDER FUNCTION; ASTHMA SELF-MANAGEMENT; MEDICATION ADHERENCE; HEALTH OUTCOMES; INTRANASAL CORTICOSTEROIDS; SUBLINGUAL IMMUNOTHERAPY; IMPROVE ADHERENCE; RHINITIS;
D O I
10.1080/17476348.2019.1554438
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction: Asthma and allergic rhinitis (AR) are chronic conditions in which management needs adherence to prescribed drugs. Despite the benefits of regular maintenance of asthma and AR therapy, low adherence is a frequent issue in clinical practice. Areas covered: The aim of this review is to provide a targeted analysis of the more recent literature on adherence in asthma and AR, focused on the following areas: adherence extent, barriers and consequences, effects of educational interventions and use of new technologies to improve the level of adherence. Expert commentary: Despite the extent, reasons and effects of this problem being well known, nonadherence in asthma and allergic AR remains worryingly high. Poor adherence leads to unsatisfactory health outcomes, with a negative impact on patients and society. Recent literature suggests that successful programs to improve adherence should include a combination of strategies. The new technologies represent a promising tool to improve adherence.
引用
收藏
页码:53 / 62
页数:10
相关论文
共 50 条
  • [21] TREATMENT OF ALLERGIC DISEASES
    SAINTPIERRE, JP
    UNION MEDICALE DU CANADA, 1985, 114 (01): : 41 - 45
  • [22] TREATMENT OF ALLERGIC DISEASES
    RAAB, W
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 1989, 139 (6-7) : 165 - &
  • [23] THE TREATMENT OF ALLERGIC DISEASES
    LOWELL, FC
    MEDICAL CLINICS OF NORTH AMERICA, 1948, (NBOST) : 1369 - 1376
  • [24] Allergic diseases of the respiratory tract - Diagnosis and treatment as exemplified in the case of bronchial asthma
    Schultze-Werninghaus, G
    INTERNIST, 2001, 42 (08): : 1096 - +
  • [25] Novel Anti-Cytokine Strategies for Prevention and Treatment of Respiratory Allergic Diseases
    Gubernatorova, Ekaterina O.
    Namakanova, Olga A.
    Gorshkova, Ekaterina A.
    Medvedovskaya, Alexandra D.
    Nedospasov, Sergei A.
    Drutskaya, Marina S.
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [26] Omalizumab: an anti-immunoglobulin E antibody for the treatment of allergic respiratory diseases
    Bousquet, J.
    Wahn, U.
    Meltzer, E. O.
    Fox, H.
    Hedgecock, S.
    Thomas, K.
    Fowler-Taylor, A.
    EUROPEAN RESPIRATORY REVIEW, 2008, 17 (107): : 1 - 9
  • [27] Medication adherence in allergic diseases and asthma: a literature review
    Malaya, Elizabeth
    Piatkowska, Adrianna
    Panek, Michal
    Kuna, Piotr
    Kupczyk, Maciej
    Kardas, Grzegorz
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [28] PREVENTIVE ASPECTS OF ALLERGIC RESPIRATORY-DISEASES
    MOLINA, MC
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 1981, 165 (06): : 747 - 752
  • [29] Allergen Immunotherapy in children with respiratory allergic diseases
    Arasi, Stefania
    Pajno, Giovanni B.
    Panasiti, Ilenia
    Sandoval, Monica
    Alvaro-Lozano, Montserrat
    MINERVA PEDIATRICA, 2020, 72 (05) : 343 - 357
  • [30] The increase in allergic respiratory diseases - Survival of the fittest?
    Varner, AE
    CHEST, 2002, 121 (04) : 1308 - 1316